Intracellular Th (ITCI) had the highest return in January 2014 by a large-cap US stock, returning 94%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Intracellular Th (ITCI) | January 2014 | 94% |
Neurocrine Biosciences (NBIX) | January 2014 | 84.36% |
TKO (TKO) | January 2014 | 46.16% |
MakeMyTrip (MMYT) | January 2014 | 43.41% |
Illumina (ILMN) | January 2014 | 37.58% |
American Airlines (AAL) | January 2014 | 33.83% |
Alnylam Pharmaceuticals (ALNY) | January 2014 | 30.21% |
Incyte (INCY) | January 2014 | 30.21% |
United Airlines (UAL) | January 2014 | 21.59% |
Tesla (TSLA) | January 2014 | 21.1% |
Insmed (INSM) | January 2014 | 20.69% |
Super Micro Computer (SMCI) | January 2014 | 20.66% |
AngloGold Ashanti (AU) | January 2014 | 20.59% |
Sarepta Therapeutics (SRPT) | January 2014 | 20.34% |
F5 Networks (FFIV) | January 2014 | 18.36% |
Juniper Networks (JNPR) | January 2014 | 17.9% |
Franco-Nevada (FNV) | January 2014 | 17.76% |
EPAM Systems (EPAM) | January 2014 | 17.6% |
Logitech International (LOGI) | January 2014 | 16.65% |
Acuity Brands (AYI) | January 2014 | 16.43% |
Insulet (PODD) | January 2014 | 16.22% |
Globus Medical (GMED) | January 2014 | 16.13% |
NVR (NVR) | January 2014 | 15.92% |
Electronic Arts (EA) | January 2014 | 15.28% |
Manhattan Associates (MANH) | January 2014 | 15.17% |
Large-cap stocks are treated as having a market cap of $10B+.
